Legal & General Group’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5,467
| Closed | -$12.4K | – | 3418 |
|
|
2024
Q2 | $12.4K | Buy |
+5,467
| New | +$12.4K | ﹤0.01% | 3234 |
|
|
2023
Q2 | – | Sell |
-2,358
| Closed | -$6.32K | – | 3541 |
|
|
2023
Q1 | $6.32K | Sell |
2,358
-9,213
| -80% | -$24.7K | ﹤0.01% | 3269 |
|
|
2022
Q4 | $62.8K | Buy |
+11,571
| New | +$62.8K | ﹤0.01% | 2909 |
|
|
2022
Q2 | – | Sell |
-19,837
| Closed | -$150K | – | 3695 |
|
|
2022
Q1 | $150K | Buy |
19,837
+110
| +0.6% | +$832 | ﹤0.01% | 2766 |
|
|
2021
Q4 | $201K | Buy |
19,727
+8,986
| +84% | +$91.6K | ﹤0.01% | 2723 |
|
|
2021
Q3 | $144K | Buy |
10,741
+5,805
| +118% | +$77.8K | ﹤0.01% | 2775 |
|
|
2021
Q2 | $109K | Sell |
4,936
-100
| -2% | -$2.21K | ﹤0.01% | 2705 |
|
|
2021
Q1 | $121K | Buy |
5,036
+456
| +10% | +$11K | ﹤0.01% | 2567 |
|
|
2020
Q4 | $83K | Sell |
4,580
-181
| -4% | -$3.28K | ﹤0.01% | 2639 |
|
|
2020
Q3 | $55K | Sell |
4,761
-1,407
| -23% | -$16.3K | ﹤0.01% | 2666 |
|
|
2020
Q2 | $149K | Buy |
6,168
+38
| +0.6% | +$918 | ﹤0.01% | 2428 |
|
|
2020
Q1 | $68K | Sell |
6,130
-1,549
| -20% | -$17.2K | ﹤0.01% | 2515 |
|
|
2019
Q4 | $203K | Buy |
7,679
+818
| +12% | +$21.6K | ﹤0.01% | 2396 |
|
|
2019
Q3 | $157K | Buy |
6,861
+689
| +11% | +$15.8K | ﹤0.01% | 2404 |
|
|
2019
Q2 | $189K | Buy |
6,172
+2,112
| +52% | +$64.7K | ﹤0.01% | 2362 |
|
|
2019
Q1 | $68K | Hold |
4,060
| – | – | ﹤0.01% | 2616 |
|
|
2018
Q4 | $78K | Buy |
4,060
+676
| +20% | +$13K | ﹤0.01% | 2533 |
|
|
2018
Q3 | $177K | Buy |
3,384
+133
| +4% | +$6.96K | ﹤0.01% | 2361 |
|
|
2018
Q2 | $141K | Buy |
3,251
+863
| +36% | +$37.4K | ﹤0.01% | 2388 |
|
|
2018
Q1 | $88K | Buy |
2,388
+628
| +36% | +$23.1K | ﹤0.01% | 2510 |
|
|
2017
Q4 | $35K | Buy |
1,760
+455
| +35% | +$9.05K | ﹤0.01% | 2988 |
|
|
2017
Q3 | $32K | Buy |
1,305
+1,141
| +696% | +$28K | ﹤0.01% | 3050 |
|
|
2017
Q2 | $3K | Buy |
+164
| New | +$3K | ﹤0.01% | 3349 |
|